Cb Pharma Ltd
Information technology consultancy activities
Cb Pharma Ltd contacts: address, phone, fax, email, website, shedule
Address: 21 Challenge House 616 Mitcham Road CR0 3AA Croydon
Phone: +44-1526 8224609
Fax: +44-1208 1688842
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Cb Pharma Ltd"? - send email to us!
Registration data Cb Pharma Ltd
Register date: 2013-09-16
Register number: 08692208
Type of company: Private Limited Company
Get full report form global database UK for Cb Pharma LtdOwner, director, manager of Cb Pharma Ltd
Christopher Leonard Boakye Director. Address: Challenge House, 616 Mitcham Road, Croydon, Surrey, CR0 3AA, England. DoB: April 1963, British
Jobs in Cb Pharma Ltd vacancies. Career and practice on Cb Pharma Ltd. Working and traineeship
Package Manager. From GBP 2400
Carpenter. From GBP 2400
Other personal. From GBP 1300
Fabricator. From GBP 2600
Responds for Cb Pharma Ltd on FaceBook
Read more comments for Cb Pharma Ltd. Leave a respond Cb Pharma Ltd in social networks. Cb Pharma Ltd on Facebook and Google+, LinkedIn, MySpaceAddress Cb Pharma Ltd on google map
Other similar UK companies as Cb Pharma Ltd: Bask Technology Limited | Aqua Padding Limited | Blends Limited | Mattei Compressors Limited | Storm Graphics Limited
This company is located in Croydon under the ID 08692208. The company was started in 2013. The office of the company is situated at 21 Challenge House 616 Mitcham Road. The postal code for this place is CR0 3AA. This business principal business activity number is 62020 - Information technology consultancy activities. The latest records cover the period up to Wed, 30th Sep 2015 and the most current annual return was filed on Wed, 16th Sep 2015. This business reached a high level of success right after the company originated in this field of business three years ago.
Right now, this particular limited company is overseen by a solitary managing director: Christopher Leonard Boakye, who was assigned this position in September 2013.
